LGC — which is based in London and backed by the private equity firm KKR — is a life sciences measurement and analytical testing company serving the pharmaceutical, food, environmental and government sectors. Profits rose to £48.8m in March last year, following the acquisition of three companies, including the Californian genomics firm Biosearch Technologies. Since the year end, chief executive Tim Robinson, 53, has continued his buy-and-build strategy, completing six acquisitions, including a majority stake in American genomics automation business Douglas Scientific, and BRC Global Standards, which LGC says is the world’s largest provider of programmes that assess the safety and quality of a wide range of food and non-food products.
This profile reflects the company at time of publication and does not reflect any changes that may have subsequently occurred. Fast Track and its sponsors do not endorse, guarantee or recommend investment in any of the companies.